PEXIVAS study visit forms
Contact Details and Assessment Schedule
Baseline
Download and Complete Form 1.1: Randomisation Notepad
Download and Complete Form 1.2: Entry
Baseline
|
Other forms to be completed at this visit
|
Required
|
Samples to be collected at this visit
|
Required (for patients that have consented to sample collection)
|
|
BVAS/WG
|
Yes
|
DNA Pax Tube
|
Yes
|
|
CDA
|
Yes
|
RNA Pax Tube
|
Yes
|
|
SF-36
|
Yes
|
Serum Tube
|
Yes
|
|
EQ-5D
|
Yes
|
Plasma Tube
|
Yes
|
|
|
|
Renal Biopsy
|
Yes
|
Week 2
Download and Complete Form 2.1: Week 2 Follow-up
|
Other forms to be completed at this visit
|
Required
|
Samples to be collected at this visit
|
Required (for patients that have consented to sample collection)
|
|
BVAS/WG
|
Yes
|
DNA Pax Tube
|
No
|
|
CDA
|
No
|
RNA Pax Tube
|
No
|
|
SF-36
|
No
|
Serum Tube
|
Yes
|
|
EQ-5D
|
No
|
Plasma Tube
|
Yes
|
Week 4
Download and Complete Form 3.1: Week 4 Follow-up
|
Other forms to be completed at this visit
|
Required
|
Samples to be collected at this visit
|
Required (for patients that have consented to sample collection)
|
|
BVAS/WG
|
Yes
|
DNA Pax Tube
|
No
|
|
CDA
|
No
|
RNA Pax Tube
|
No
|
|
SF-36
|
No
|
Serum Tube
|
No
|
|
EQ-5D
|
No
|
Plasma Tube
|
No
|
Week 8
Download and Complete Form 4.1: Week 8 Follow-up
|
Other forms to be completed at this visit
|
Required
|
Samples to be collected at this visit
|
Required (for patients that have consented to sample collection)
|
|
BVAS/WG
|
Yes
|
DNA Pax Tube
|
No
|
|
CDA
|
No
|
RNA Pax Tube
|
No
|
|
SF-36
|
No
|
Serum Tube
|
No
|
|
EQ-5D
|
No
|
Plasma Tube
|
No
|
Week 12
Download and Complete Form 5.1: Week 12 Follow-up
|
Other forms to be completed at this visit
|
Required
|
Samples to be collected at this visit
|
Required (for patients that have consented to sample collection)
|
|
BVAS/WG
|
Yes
|
DNA Pax Tube
|
No
|
|
CDA
|
Yes
|
RNA Pax Tube
|
Yes
|
|
SF-36
|
Yes
|
Serum Tube
|
Yes
|
|
EQ-5D
|
Yes
|
Plasma Tube
|
Yes
|
Week 26
Download and Complete Form 6.1: Week 26 Follow-up
|
Other forms to be completed at this visit
|
Required
|
Samples to be collected at this visit
|
Required (for patients that have consented to sample collection)
|
|
BVAS/WG
|
Yes
|
DNA Pax Tube
|
No
|
|
CDA
|
Yes
|
RNA Pax Tube
|
No
|
|
SF-36
|
Yes
|
Serum Tube
|
No
|
|
EQ-5D
|
Yes
|
Plasma Tube
|
No
|
Week 39
Download and Complete Form 7.1: Week 39 Follow-up
|
Other forms to be completed at this visit
|
Required
|
Samples to be collected at this visit
|
Required (for patients that have consented to sample collection)
|
|
BVAS/WG
|
Yes
|
DNA Pax Tube
|
No
|
|
CDA
|
No
|
RNA Pax Tube
|
No
|
|
SF-36
|
No
|
Serum Tube
|
No
|
|
EQ-5D
|
No
|
Plasma Tube
|
No
|
Week 52
Download and Complete Form 8.1: Week 52 Follow-up
|
Other forms to be completed at this visit
|
Required
|
Samples to be collected at this visit
|
Required (for patients that have consented to sample collection)
|
|
BVAS/WG
|
Yes
|
DNA Pax Tube
|
No
|
|
CDA
|
Yes
|
RNA Pax Tube
|
Yes
|
|
SF-36
|
Yes
|
Serum Tube
|
Yes
|
|
EQ-5D
|
Yes
|
Plasma Tube
|
Yes
|
6 Monthly
Download and Complete Form 9.1: 6 Monthly Follow-up
|
Other forms to be completed at this visit
|
Required
|
Samples to be collected at this visit
|
Required (for patients that have consented to sample collection)
|
|
BVAS/WG
|
Yes
|
DNA Pax Tube
|
No
|
|
CDA
|
Yes
|
RNA Pax Tube
|
No
|
|
SF-36
|
Yes
|
Serum Tube
|
No
|
|
EQ-5D
|
Yes
|
Plasma Tube
|
No
|
PEXIVAS outcome forms
Form 10: Death
Form 11: ESRD
Form 12: Resistant Disease
Form 13: Relapse
Form 14: SAE
Form 15: Infection
Form 16: Plasma Exchange
Form 17: Lung Haemorrhage
Form 18: Remission: Remission information should be reported on the Follow-Up Form from Week 4 onwards.
Form 19: BVAS/WG
Form 20: CDA
Form 21: SF-36 - Please contact the PEXIVAS Office
Header Sheet for Inclusion with Translated SF-36 Forms
Form 22: Deviation from Glucocorticoid Dose
Form 23: EQ-5D
Header Sheet for Inclusion with Translated EQ-5D Forms
To calculate A-a O2 gradient please use the following link:
http://www.mdcalc.com/a-a-o2-gradient
PEXIVAS Protocol
Centres should contact the PEXIVAS Study Office in Cambridge for the full protocol - please email Biljana Brezina at bjovanovska@nhs.net